Skip to main content
. 2017 Feb 13;14(3):908–915. doi: 10.1021/acs.molpharmaceut.6b01130

Figure 5.

Figure 5

PET imaging studies in two mice with orthotopically implanted capan-2 xenografts that were administered 100 μg of unlabeled 5B1 4 h prior to 89Zr-5B1. Tomographic slices and MIPs from PET scans at 48 and 120 h postinjection (A) as well as PET/CT images (B,C) acquired at 120 h postinjection of 89Zr-5B1 are shown.